These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28608234)

  • 1. Genomics-Guided Precise Anti-Epileptic Drug Development.
    Delanty N; Cavalleri G
    Neurochem Res; 2017 Jul; 42(7):2084-2088. PubMed ID: 28608234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying mutations in epilepsy genes: Impact on treatment selection.
    Perucca P; Perucca E
    Epilepsy Res; 2019 May; 152():18-30. PubMed ID: 30870728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A roadmap for precision medicine in the epilepsies.
    EpiPM Consortium
    Lancet Neurol; 2015 Dec; 14(12):1219-28. PubMed ID: 26416172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in genetic epilepsies: break of dawn?
    Reif PS; Tsai MH; Helbig I; Rosenow F; Klein KM
    Expert Rev Neurother; 2017 Apr; 17(4):381-392. PubMed ID: 27781560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systems-level framework for anti-epilepsy drug discovery.
    Johnson MR; Kaminski RM
    Neuropharmacology; 2020 Jun; 170():107868. PubMed ID: 31785261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Epileptic Encephalopathies.
    Balestrini S; Sisodiya SM
    Curr Pharm Des; 2017; 23(37):5667-5690. PubMed ID: 28799511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of response to quinidine in KCNT1-related neonatal epilepsy.
    Numis AL; Nair U; Datta AN; Sands TT; Oldham MS; Patel A; Li M; Gazina E; Petrou S; Cilio MR
    Epilepsia; 2018 Oct; 59(10):1889-1898. PubMed ID: 30182418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Discoveries Drive Molecular Analyses and Targeted Therapeutic Options in the Epilepsies.
    Dhindsa RS; Goldstein DB
    Curr Neurol Neurosci Rep; 2015 Oct; 15(10):70. PubMed ID: 26319171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies.
    Brock DC; Demarest S; Benke TA
    Neurotherapeutics; 2021 Jul; 18(3):1445-1457. PubMed ID: 34595733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency.
    Daci A; Bozalija A; Jashari F; Krasniqi S
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29303961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing epilepsy genetics in the genomic era.
    Myers CT; Mefford HC
    Genome Med; 2015 Aug; 7(1):91. PubMed ID: 26302787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy.
    Dilena R; DiFrancesco JC; Soldovieri MV; Giacobbe A; Ambrosino P; Mosca I; Galli MA; Guez S; Fumagalli M; Miceli F; Cattaneo D; Darra F; Gennaro E; Zara F; Striano P; Castellotti B; Gellera C; Varesio C; Veggiotti P; Taglialatela M
    Neurotherapeutics; 2018 Oct; 15(4):1112-1126. PubMed ID: 30112700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The path from scientific discovery to cures for epilepsy.
    Carvill GL; Dulla CG; Lowenstein DH; Brooks-Kayal AR
    Neuropharmacology; 2020 May; 167():107702. PubMed ID: 31301334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of next generation sequencing to epilepsy genetics.
    Møller RS; Dahl HA; Helbig I
    Expert Rev Mol Diagn; 2015; 15(12):1531-8. PubMed ID: 26565596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in epilepsy genomics and genetic testing.
    Hebbar M; Mefford HC
    F1000Res; 2020; 9():. PubMed ID: 32201576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New use for an old drug: quinidine in KCNT1-related epilepsy therapy.
    Liu R; Sun L; Wang Y; Wang Q; Wu J
    Neurol Sci; 2023 Apr; 44(4):1201-1206. PubMed ID: 36437393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing epilepsy treatment through personalized genetic zebrafish models.
    Griffin A; Krasniak C; Baraban SC
    Prog Brain Res; 2016; 226():195-207. PubMed ID: 27323944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.
    Mei D; Parrini E; Marini C; Guerrini R
    Mol Diagn Ther; 2017 Aug; 21(4):357-373. PubMed ID: 28197949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic and clinical analysis of children with early-onset epilepsy encephalopathy caused by KCNT1 gene mutation].
    Chen Y; Bao XH; Zhang QP; Wang JP; Wen YX; Yu SJ; Zhao Y
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):824-828. PubMed ID: 30392206
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiepileptic Drugs in Clinical Development: Differentiate or Die?
    Zaccara G; Schmidt D
    Curr Pharm Des; 2017; 23(37):5593-5605. PubMed ID: 28799516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.